The S&P BSE Sensex ended the session at 25,342, up 3 points while the Nifty50 closed at 7,738 points.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The number of small units has come down drastically, as large companies have expanded their manufacturing capacity.
The Nifty had hit its third successive record high of 7,922.70 today.
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
One reason Japan is betting highly on Indian pharma is that these companies have strong cash flows, low leverage and high debt capacity for medium to large sized acquisitions.
Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine broader markets.
Broader markets outperformed with BSE Midcap and BSE Smallcap adding 0.23% and 0.45%, respectively
The 30-share Sensex ended down 32 points at 28,851 and the 50-share Nifty closed 12 points lower at 8,712.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
Large and small businesses alike have delivered low-key performances.
The country had the third-largest number of people living with disease.
Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.
Sensex, Nifty put up a good show in closing trade.
Markets in green tracking firm global cues.
Analysts mostly prefer domestic plays beside select films with foreign exposure.
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries:
T N Ninan lists a few David-Goliath encounters in the Indian markets, all of which make life interesting, though difficult if you are an investor looking for the next multi-bagger.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances